anti-DLL3 CAR-NK cells
Term · Oncology and biomedicine · MLC-T-ONC-010574
A preparation of natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) delta-like protein 3 (DLL3), with potential immunomodulating and antineoplastic activities. Upon administration, the anti-DLL3 CAR-NK cells recognize, bind to and induce selective cytotoxicity in DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.
| Identifier | MLC-T-ONC-010574 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | DLL3-CAR-NK cells; DLL3-CAR-natural killer cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010574",
"term": "anti-DLL3 CAR-NK cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of natural killer (NK) cells engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) delta-like protein 3 (DLL3), with potential immunomodulating and antineoplastic activities. Upon administration, the anti-DLL3 CAR-NK cells recognize, bind to and induce selective cytotoxicity in DLL3-expressing tumor cells. DLL3, a Notch pathway protein, is overexpressed on a variety of cancer cell types. It plays a key role in embryonic development and in tumor initiation and proliferation.",
"synonyms": [
"DLL3-CAR-NK cells",
"DLL3-CAR-natural killer cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-dll3-car-nk-cells/"
}
Record 1,670 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.